Publications by authors named "Pascal Urwyler"

Claim this Profile
A
Aerosolization of Mycobacterium chelonae from heater-cooler-devices: a continuing risk of exposure during cardiac surgery.
Sabine Kuster, Pascal Urwyler, Gioele Capoferri, Matthias Von Rotz, Silvio Ragozzino

Antimicrob Resist Infect Control· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxigenic Corynebacterium diphtheriae Infections in Low-Risk Patients, Switzerland, 2023.
Pascal Urwyler, Daniel Goldenberger, Kerstin Grosheintz, Rahel Tarnutzer, Maike Markstein

Emerg Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening sites for detection of carbapenemase-producers- a retrospective cohort study.
Isabelle Vock, Silvio Ragozzino, Pascal Urwyler, Michelle Baumann, Gioele Capoferri

Antimicrob Resist Infect Control· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms.
Silvio Ragozzino, Richard Kuehl, Karoline Leuzinger, Pascal Schläpfer, Pascal Urwyler

Antimicrob Resist Infect Control· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diphtheria in a Swiss Asylum Seeker Reception Centre: Outbreak Investigation and Evaluation of Testing and Vaccination Strategies.
Lisa Brockhaus, Pascal Urwyler, Ulrike Leutwyler, Eva Würfel, Malte Kohns Vasconcelos

Int J Public Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Pascal Urwyler, Marina Leimbacher, Panteleimon Charitos, Stephan Moser, Ingmar A F M Heijnen

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort.
Nebal S Abu Hussein, Stephanie Giezendanner, Pascal Urwyler, Pierre-Olivier Bridevaux, Prashant N Chhajed

J Clin Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation.
Gioele Capoferri, Carla Simone Walti, Pascal Urwyler, Silvio Ragozzino, Jakob R Passweg

Bone Marrow Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression.
Pascal Urwyler, Stephan Moser, Marten Trendelenburg, Parham Sendi, Michael Osthoff

Mol Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Pascal Urwyler, Panteleimon Charitos, Stephan Moser, Ingmar A F M Heijnen, Marten Trendelenburg

Trials· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.
Pascal Urwyler, Stephan Moser, Panteleimon Charitos, Ingmar A F M Heijnen, Melanie Rudin

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
Pascal Urwyler, Maria Boesing, Kristin Abig, Marco Cattaneo, Thomas Dieterle

Trials· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort.
Pascal Urwyler, Nebal Abu Hussein, Pierre O Bridevaux, Prashant N Chhajed, Thomas Geiser

Multidiscip Respir Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programme.
Tania Carron, Pierre-Olivier Bridevaux, Karin Lörvall, Rachel Parmentier, Jean-Bernard Moix, Pascal Urwyler

Swiss Med Wkly· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against vaccine-preventable diseases in medical students: a follow up.
Pascal Urwyler, Alexa Dierig, Kathi Walther, Ulrich Heininger

Pediatr Infect Dis J· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protecting newborns from pertussis - the challenge of complete cocooning.
Pascal Urwyler, Ulrich Heininger

BMC Infect Dis· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis